Rabeprazole sodium and Polymyalgia rheumatica aggravated - a phase IV clinical study of FDA data


No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

No or too few reports are found.

What is Rabeprazole Sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 14,654 Rabeprazole sodium users.

What is Polymyalgia Rheumatica Aggravated?

Polymyalgia rheumatica aggravated (serious pain in many muscles) is found to be associated with 857 drugs and 258 conditions by eHealthMe. Currently, we are studying 20 people who have Polymyalgia rheumatica aggravated.

Do you take Rabeprazole sodium and have Polymyalgia rheumatica aggravated?

Check whether Polymyalgia rheumatica aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Rabeprazole sodium side effects by duration, gender and age:

Polymyalgia rheumatica aggravated treatments and more:

All the drugs that are associated with Polymyalgia rheumatica aggravated:

All the conditions that are associated with Polymyalgia rheumatica aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole sodium) and Rabeprazole sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: